Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BELLUS Health Inc. stock logo
BLU
BELLUS Health
$14.74
$14.62
$6.38
$14.76
$1.87B0.193.08 million shs3.45 million shs
Cel-Sci Corporation stock logo
CVM
Cel-Sci
$10.09
-0.2%
$9.61
$1.98
$32.70
$69.42M0.52335,795 shs1,650 shs
PAR Technology Corporation stock logo
PAR
PAR Technology
$35.30
-1.3%
$45.21
$35.02
$82.24
$1.44B1.65577,856 shs123,967 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BELLUS Health Inc. stock logo
BLU
BELLUS Health
0.00%0.00%0.00%0.00%0.00%
Cel-Sci Corporation stock logo
CVM
Cel-Sci
+2.43%+0.80%+2.43%+142.45%-64.68%
PAR Technology Corporation stock logo
PAR
PAR Technology
-2.74%-4.30%-17.24%-48.89%-37.40%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BELLUS Health Inc. stock logo
BLU
BELLUS Health
$14.74
$14.62
$6.38
$14.76
$1.87B0.193.08 million shs3.45 million shs
Cel-Sci Corporation stock logo
CVM
Cel-Sci
$10.09
-0.2%
$9.61
$1.98
$32.70
$69.42M0.52335,795 shs1,650 shs
PAR Technology Corporation stock logo
PAR
PAR Technology
$35.30
-1.3%
$45.21
$35.02
$82.24
$1.44B1.65577,856 shs123,967 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BELLUS Health Inc. stock logo
BLU
BELLUS Health
0.00%0.00%0.00%0.00%0.00%
Cel-Sci Corporation stock logo
CVM
Cel-Sci
+2.43%+0.80%+2.43%+142.45%-64.68%
PAR Technology Corporation stock logo
PAR
PAR Technology
-2.74%-4.30%-17.24%-48.89%-37.40%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BELLUS Health Inc. stock logo
BLU
BELLUS Health
0.00
N/AN/AN/A
Cel-Sci Corporation stock logo
CVM
Cel-Sci
0.00
N/AN/AN/A
PAR Technology Corporation stock logo
PAR
PAR Technology
2.60
Moderate Buy$74.57111.24% Upside

Current Analyst Ratings Breakdown

Latest BLU, PAR, CVM, and OXB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/14/2025
PAR Technology Corporation stock logo
PAR
PAR Technology
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
10/13/2025
PAR Technology Corporation stock logo
PAR
PAR Technology
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$50.00 ➝ $38.00
10/8/2025
PAR Technology Corporation stock logo
PAR
PAR Technology
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
9/27/2025
PAR Technology Corporation stock logo
PAR
PAR Technology
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
8/19/2025
PAR Technology Corporation stock logo
PAR
PAR Technology
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$92.00 ➝ $77.00
8/15/2025
PAR Technology Corporation stock logo
PAR
PAR Technology
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeNeutralBuy$65.00
(Data available from 10/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BELLUS Health Inc. stock logo
BLU
BELLUS Health
$15K124,613.93N/AN/A$3.09 per share4.77
Cel-Sci Corporation stock logo
CVM
Cel-Sci
N/AN/AN/AN/A$6.06 per shareN/A
PAR Technology Corporation stock logo
PAR
PAR Technology
$349.98M4.09N/AN/A$22.51 per share1.57
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BELLUS Health Inc. stock logo
BLU
BELLUS Health
-$76.08M-$0.72N/AN/AN/A-578,586.63%-24.27%-23.14%N/A
Cel-Sci Corporation stock logo
CVM
Cel-Sci
-$26.92M-$9.77N/AN/AN/AN/A-259.38%-107.21%N/A
PAR Technology Corporation stock logo
PAR
PAR Technology
-$4.99M-$2.25N/AN/AN/A-20.64%-3.16%-1.90%11/14/2025 (Estimated)

Latest BLU, PAR, CVM, and OXB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/8/2025Q2 2025
PAR Technology Corporation stock logo
PAR
PAR Technology
$0.04$0.03-$0.01-$0.52$111.02 million$112.40 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/AN/AN/AN/AN/A
Cel-Sci Corporation stock logo
CVM
Cel-Sci
N/AN/AN/AN/AN/A
PAR Technology Corporation stock logo
PAR
PAR Technology
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/A
33.42
33.42
Cel-Sci Corporation stock logo
CVM
Cel-Sci
0.89
0.47
0.37
PAR Technology Corporation stock logo
PAR
PAR Technology
0.43
1.70
1.49

Institutional Ownership

CompanyInstitutional Ownership
BELLUS Health Inc. stock logo
BLU
BELLUS Health
90.37%
Cel-Sci Corporation stock logo
CVM
Cel-Sci
12.08%
PAR Technology Corporation stock logo
PAR
PAR Technology
N/A

Insider Ownership

CompanyInsider Ownership
BELLUS Health Inc. stock logo
BLU
BELLUS Health
24.17%
Cel-Sci Corporation stock logo
CVM
Cel-Sci
9.93%
PAR Technology Corporation stock logo
PAR
PAR Technology
3.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
BELLUS Health Inc. stock logo
BLU
BELLUS Health
74126.81 million96.16 millionNot Optionable
Cel-Sci Corporation stock logo
CVM
Cel-Sci
436.88 million6.20 millionOptionable
PAR Technology Corporation stock logo
PAR
PAR Technology
1,58540.58 million39.08 millionOptionable

Recent News About These Companies

William Blair Reiterates Outperform Rating for PAR Technology (NYSE:PAR)
PAR Technology Corporation's Recent Stumbles
PAR Technology (NYSE:PAR) Reaches New 1-Year Low Following Analyst Downgrade
Refuel Begins Rollout of Unified Loyalty Program
Refuel partners with PAR to combine loyalty and data
PAR Technology Corporation (PAR): A Bull Case Theory
3 Reasons to Sell PAR and 1 Stock to Buy Instead

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
BELLUS Health stock logo

BELLUS Health NASDAQ:BLU

BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.

Cel-Sci stock logo

Cel-Sci NYSEAMERICAN:CVM

$10.09 -0.02 (-0.20%)
As of 10:21 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development of immune system therapy for the treatment of cancer and other diseases in the United States. The company's lead immunotherapy is Multikine, which has completed Phase 3 clinical trials for the potential treatment of certain head and neck cancers. It is also developing products based on its proprietary technology Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer. In addition, the company's product pipeline includes CEL-2000; CEL-4000; and CEL-5000, which are LEAPS-based product candidates in preclinical trials for the treatment of rheumatoid arthritis disease. CEL-SCI Corporation was incorporated in 1983 and is headquartered in Vienna, Virginia.

PAR Technology stock logo

PAR Technology NYSE:PAR

$35.30 -0.45 (-1.25%)
As of 10:22 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PAR Technology Corporation, together with its subsidiaries, provides omnichannel cloud-based hardware and software solutions to the restaurant and retail industries worldwide. The Restaurant/Retail segment offers PUNCHH, an enterprise-grade customer loyalty and engagement solution; MENU, an eCommerce platform for restaurant brands; BRINK POS, an open cloud, point-of-sale solution; PAR PAYMENT SERVICES, a merchant services business that enables electronic payment and processing services for businesses; and DATA CENTRAL, a back-office solution that leverages business intelligence and automation technologies. This segment also offers Point-of-Sale Hardware; wireless headsets for drive-thru order-taking; and kitchen display systems, payment devices, cash drawers, printers, and other peripherals. In addition, this segment provides services, such as hardware repair, installation and implementation, training, and on-site and technical support services. The Government segment provides intelligence, surveillance, and reconnaissance solutions; mission systems operations and maintenance, and commercial software products; systems engineering support and software-based solutions; satellite and teleport facility operation and maintenance, engineering, and installation services comprising inside and outside plant services, and maintenance of infrastructure and information systems; satellite ground system support comprising operations and maintenance, sustainment, upgrades, communications security management, anomaly response/resolution, process improvement, emergency response, and disaster recovery services; and information technology infrastructure library services to the United States Department of Defense, intelligence community (IC), and other federal agencies. This segment also offers various IC support services, systems integration, situational awareness solutions, and mission readiness support services. The company was founded in 1968 and is based in New Hartford, New York.